5 observations on Smith & Nephew's stock rating downgrade

Spinal Tech

Zacks downgraded Smith & Nephew from a "hold" rating to a "sell" rating, according to a Dakota Financial News report.

Here are five observations:

 

1. The company currently has a consensus target price of $40.97.

 

2. Smith & Nephew has a one-year low of $28.87 and a one-year high of $39.80.

 

3. The stock's 50-day moving average is $34.50 and its 200-day moving average is $35.04.

 

4. The company has a market cap of $15.94 billion.

 

5. In June, Smith & Nephew announced plans to acquire Zimmer's unicondylar knee system in the United States market.

 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers